Intervention with fish oil, but not with docosahexaenoic acid, results in lower levels of hepatic soluble epoxide hydrolase with time in apoE knockout mice

British Journal of Nutrition

Volumn 103, Issue 1, 2010, Pages 16-24

  Mavrommatis, Yiannis ^a   Ross, Karen ^a   Rucklidge, Garry ^a   Reid, Martin ^a   Duncan, Gary ^a   Gordon, Margaret Jane ^a   Thies, Frank ^a,b   Sneddon, Alan ^a   De Roos, Baukje ^a  

^a ROWETT RESEARCH INSTITUTE   (United Kingdom)

^b UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

Atherosclerosis; Epoxyeicosatrienoic acids; N 3 Fatty acids; Proteomics

Indexed keywords

2 OXOISOVALERATE DEHYDROGENASE (LIPOAMIDE); 2,4 DIENOYL COENZYME A REDUCTASE (NADPH); 3 HYDROXYANTHRANILATE 3,4 DIOXYGENASE; ALDEHYDE DEHYDROGENASE; ALPHA ENOLASE; APOLIPOPROTEIN A1; APOLIPOPROTEIN E; DOCOSAHEXAENOIC ACID; DRONABINOL; EPOXIDE HYDROLASE; FATTY ACID; FISH OIL; FORMATE TETRAHYDROFOLATE LIGASE; FRUCTOSE BISPHOSPHATASE; GLUTAMATE DEHYDROGENASE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; HEAT SHOCK PROTEIN 60; HYDROXYPYRUVATE REDUCTASE; ISOVALERYL COENZYME A DEHYDROGENASE; KETOHEXOKINASE; LIPOPROTEIN; METHIONINE ADENOSYLTRANSFERASE; NEUROMINS; ORNITHINE OXOACID AMINOTRANSFERASE; PEROXIREDOXIN; PHENYLALANINE 4 MONOOXYGENASE; PROTEOME; PYRIDOXAL KINASE; SELENIUM BINDING PROTEIN; SUNFLOWER OIL; TRANSCRIPTION FACTOR FKHRL1; UNCLASSIFIED DRUG; FORKHEAD TRANSCRIPTION FACTOR; FOXO3 PROTEIN, MOUSE; OLEIC ACID; PRIMER DNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA; AORTA ROOT; ARTICLE; ATHEROSCLEROTIC PLAQUE; CHOLESTEROL DIET; CONTROLLED STUDY; KNOCKOUT MOUSE; LIPID COMPOSITION; LIPID DIET; LIPOPROTEIN METABOLISM; LIVER PARENCHYMA; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; POLYACRYLAMIDE GEL ELECTROPHORESIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TREATMENT OUTCOME; ANIMAL; ATHEROSCLEROSIS; C57BL MOUSE; CHOLESTEROL INTAKE; DRUG EFFECT; ENZYMOLOGY; FAT INTAKE; GENETICS; LIVER; METABOLISM; MOUSE MUTANT; PATHOLOGY; PLANT SEED; PROTEOMICS; SPECIES DIFFERENCE; THORACIC AORTA;

HELIANTHUS; MUS;

ANIMALS; AORTA, THORACIC; APOLIPOPROTEINS E; ATHEROSCLEROSIS; CHOLESTEROL, DIETARY; DIETARY FATS; DNA PRIMERS; DOCOSAHEXAENOIC ACIDS; EPOXIDE HYDROLASES; FISH OILS; FORKHEAD TRANSCRIPTION FACTORS; LIVER; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OLEIC ACID; PROTEOMICS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEEDS; SPECIES SPECIFICITY;

EID: 75549089077     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114509991450     Document Type: Article

References (48)

1. Kromhout D, Bosschieter EB & de Lezenne CC (1985) The inverse relation between fish consumption and 20-year mortality from coronary heart disease. N Engl J Med 312, 1205-1209.
2. Hu FB & Willett WC (2002) Optimal diets for prevention of coronary heart disease. JAMA 288, 2569-2578.
3. Hu FB, Bronner L, Willett WC, et al. (2002) Fish and omega-3 fatty acid intake and risk of coronary heart disease in women. JAMA 287, 1815-1821.
4. GISSI Investigators (1999) Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocar-dico. Lancet 354, 447-455.
5. de Roos B, Mercer DK, Wainwright C, et al. (2005) Effect of long chain n-3 PUFA on endothelial activation, endothelial function and atheromatous plaque stability. Curr Nutr Food Sci 1, 167-177.
6. Thies F, Garry JM, Yaqoob P, et al. (2003) Association of n-3 polyunsaturated fatty acids with stability of atherosclerotic plaques: a randomised controlled trial. Lancet 361, 477-485.
7. de Roos B, Mavrommatis Y & Brouwer IA (2009) Long-chain n-3 polyunsaturated fatty acids: new insights into mechanisms relating to inflammation and coronary heart disease. Br J Pharmacol (epublication ahead of print version 5 May 2009).
8. Mori TA & Woodman RJ (2006) The independent effects of eicosapentaenoic acid and docosahexaenoic acid on cardiovascular risk factors in humans. Curr Opin Clin Nutr Metab Care 9, 95-104.
9. de Roos B, Duivenvoorden I, Rucklidge G, et al. (2005) Response of apolipoprotein E*3-Leiden transgenic mice to dietary fatty acids: combining liver proteomics with physiological data. FASEB J 19, 813-815.
10. Spector AA & Norris AW (2007) Action of epoxyeicosatrienoic acids on cellular function. Am J Physiol Cell Physiol 292, C996-C1012.
11. Node K, Huo Y, Ruan X, et al. (1999) Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids. Science 285, 1276-1279.
12. Fisslthaler B, Popp R, Kiss L, et al. (1999) Cytochrome P4502C is an EDHF synthase in coronary arteries. Nature 401, 493-497.
13. Fisslthaler B, Fleming I & Busse R (2000) EDHF: a cytochrome P450 metabolite in coronary arteries. Semin Perinatol 24, 15-19.
14. Ridker PM, Vaughan DE, Stampfer MJ, et al. (1993) Endogenous tissue-type plasminogen activator and risk of myocardial infarction. Lancet 341, 1165-1168.
15. Spector AA, Fang X, Snyder GD, et al. (2004) Epoxyeicosatrie-noic acids (EETs): metabolism and biochemical function. Prog Lipid Res 43, 55-90.
16. Chiribau CB, Cheng L, Cucoranu IC, et al. (2008) FOXO3a regulates peroxiredoxin III expression in human cardiac fibro-blasts. J Biol Chem 283, 8211-8217.
17. Potente M, Fisslthaler B, Busse R, et al. (2003) 11, 12-Epoxyei- cosatrienoic acid-induced inhibition of FOXO factors promotes endothelial proliferation by down-regulating p27Kip1. J Biol Chem 278, 29619-29625.
18. Folch J, Lees M & Sloane Stanley GH (1957) A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 226, 497-509.
19. (2/2) mice. J Proteome Res 6, 4041-4054.
20. de Roos B, Rucklidge G, Reid M, et al. (2005) Divergent mechanisms of cis9, trans11-and trans10, cis12-conjugated linoleic acid affecting insulin resistance and inflammation in apolipopro-tein E knockout mice: a proteomics approach. FASEB J 19, 1746-1748.
21. de Roos B, Geelen A, Ross K, et al. (2008) Identification of potential serum biomarkers of inflammation and lipid modulation that are altered by fish oil supplementation in healthy volunteers. Proteomics 8, 1965-1974.
22. Paigen B, Morrow A, Holmes PA, et al. (1987) Quantitative assessment of atherosclerotic lesions in mice. Atherosclerosis 68, 231-240.
23. Kops GJ, Dansen TB, Polderman PE, et al. (2002) Forkhead transcription factor FOXO3a protects quiescent cells from oxidative stress. Nature 419, 316-321.
24. Nemoto S & Finkel T (2002) Redox regulation of forkhead proteins through a p66shc-dependent signaling pathway. Science 295, 2450-2452.
25. Willumsen N, Vaagenes H, Lie O, et al. (1996) Eicosapentae-noic acid, but not docosahexaenoic acid, increases mitochon-drial fatty acid oxidation and upregulates 2, 4-dienoyl-CoA reductase gene expression in rats. Lipids 31, 579-592.
26. Zhou L & Nilsson A (2001) Sources of eicosanoid precursor fatty acid pools in tissues. J Lipid Res 42, 1521-1542.
27. Madsen L, Froyland L, Dyroy E, et al. (1998) Docosahexaenoic and eicosapentaenoic acids are differently metabolized in rat liver during mitochondria and peroxisome proliferation. J Lipid Res 39, 583-593.
28. Hansen JB, Grimsgaard S, Nilsen H, et al. (1998) Effects of highly purified eicosapentaenoic acid and docosahexaenoic acid on fatty acid absorption, incorporation into serum phospholipids and postprandial triglyceridemia. Lipids 33, 131-138.
29. 13C]22:6n-3-triacylglycerols. Am J Clin Nutr 64, 577-586.
30. Morgado N, Rigotti A & Valenzuela A (2005) Comparative effect of fish oil feeding and other dietary fatty acids on plasma lipoproteins, biliary lipids, and hepatic expression of proteins involved in reverse cholesterol transport in the rat. Ann Nutr Metab 49, 397-406.
31. Thies F, Nebe-von-Caron G, Powell JR, et al. (2001) Dietary supplementation with eicosapentaenoic acid, but not with other long-chain n-3 or n-6 polyunsaturated fatty acids, decreases natural killer cell activity in healthy subjects aged.55 y. Am J Clin Nutr 73, 539-548.
32. Kim HJ, Takahashi M & Ezaki O (1999) Fish oil feeding decreases mature sterol regulatory element-binding protein 1 (SREBP-1) by down-regulation of SREBP-1c mRNA in mouse liver. A possible mechanism for down-regulation of lipo-genic enzyme mRNAs. J Biol Chem 274, 25892-25898.
33. Pinot F, Grant DF, Spearow JL, et al. (1995) Differential regulation of soluble epoxide hydrolase by clofibrate and sexual hormones in the liver and kidneys of mice. Biochem Pharmacol 50, 501-508.
34. Newman JW, Morisseau C & Hammock BD (2005) Epoxide hydrolases: their roles and interactions with lipid metabolism. Prog Lipid Res 44, 1-51.
35. Alagona C, Soro A, Ylitalo K, et al. (2002) A low high density lipoprotein (HDL) level is associated with carotid artery intima-media thickness in asymptomatic members of low HDL families. Atherosclerosis 165, 309-316.
36. Buckley R, Shewring B, Turner R, et al. (2004) Circulating tria-cylglycerol and apoE levels in response to EPA and docosahex-aenoic acid supplementation in adult human subjects. Br J Nutr 92, 477-483.
37. Williams CM, Moore F, Morgan L, et al. (1992) Effects of n-3 fatty acids on postprandial triacylglycerol and hormone concentrations in normal subjects. Br J Nutr 68, 655-666.
38. Caslake MJ, Miles EA, Kofler BM, et al. (2008) Effect of sex and genotype on cardiovascular biomarker response to fish oils: the FINGEN Study. Am J Clin Nutr 88, 618-629.
39. Fujii J & Ikeda Y (2002) Advances in our understanding of peroxiredoxin, a multifunctional, mammalian redox protein. Redox Rep 7, 123-130.
40. Wang T, Zhang X & Li JJ (2002) The role of NF-kB in the regulation of cell stress responses. Int Immunopharmacol 2, 1509-1520.
41. 2/2) mice on a high-fat diet. Proteomics 9, 3244-3256.
42. Nemoto S, Combs CA, French S, et al. (2006) The mammalian longevity-associated gene product p66shc regulates mitochon-drial metabolism. J Biol Chem 281, 10555-10560.
43. Larsen BT, Gutterman DD & Hatoum OA (2006) Emerging role of epoxyeicosatrienoic acids in coronary vascular function. Eur J Clin Invest 36, 293-300.
44. Zampolli A, Bysted A, Leth T, et al. (2006) Contrasting effect of fish oil supplementation on the development of atherosclerosis in murine models. Atherosclerosis 184, 78-85.
45. Xu Z, Riediger N, Innis S, et al. (2007) Fish oil significantly alters fatty acid profiles in various lipid fractions but not ather-ogenesis in apo E-KO mice. Eur J Nutr 46, 103-110.
46. Wang HH, Hung TM, We J, et al. (2004) Fish oil increases antioxidant enzyme activities in macrophages and reduces atherosclerotic lesions in apoE-knockout mice. Cardiovasc Res 61, 169-176.
47. (2/2) mice is associated with a reduction of endothelial adhesion molecules. Atherosclerosis 201, 306-317.
48. Matsumoto M, Sata M, Fukuda D, et al. (2008) Orally administered eicosapentaenoic acid reduces and stabilizes atherosclerotic lesions in apoE-deficient mice. Atherosclerosis 197, 524-533.